Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 4 (2007), Issue 6 (June)

1. Radiochemotherapy of esophageal cancer.
   J Thorac Oncol, 2(6): 553-68. [Abstract] [Full-text]
2. Patterns of radiotherapy re-treatment in patients with lung cancer: a retrospective, longitudinal study.
   J Thorac Oncol, 2(6): 531-6. [Abstract] [Full-text]
3. Tolerability of accelerated chest irradiation and impact on survival of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer: review of a single institution's experience.
   J Thorac Oncol, 2(6): 506-13. [Abstract] [Full-text]
4. Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.
   Laryngoscope, 117(6): 1013-8. [Abstract] [Full-text]
5. Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy.
   Int J Radiat Oncol Biol Phys, 68(3): 943-51. [Abstract] [Full-text]
6. Magnetic resonance-based treatment planning for prostate intensity-modulated radiotherapy: creation of digitally reconstructed radiographs.
   Int J Radiat Oncol Biol Phys, 68(3): 903-11. [Abstract] [Full-text]
7. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation.
   Int J Radiat Oncol Biol Phys, 68(3): 654-61. [Abstract] [Full-text]
8. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy.
   Int J Radiat Oncol Biol Phys, 68(3): 935-42. [Abstract] [Full-text]
9. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
   Int J Radiat Oncol Biol Phys, 68(3): 898-902. [Abstract] [Full-text]
10. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer.
    Int J Radiat Oncol Biol Phys, 68(3): 892-7. [Abstract] [Full-text]
11. Intensity-modulated radiotherapy using implanted fiducial markers with daily portal imaging: assessment of prostate organ motion.
    Int J Radiat Oncol Biol Phys, 68(3): 912-9. [Abstract] [Full-text]
12. Nodal ratios in node-positive breast cancer--long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy.
    Int J Radiat Oncol Biol Phys, 68(3): 662-6. [Abstract] [Full-text]
13. Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT.
    Int J Radiat Oncol Biol Phys, 68(3): 952-7. [Abstract] [Full-text]
14. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life.
    Int J Radiat Oncol Biol Phys, 68(3): 750-7. [Abstract] [Full-text]
15. Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119).
    Int J Radiat Oncol Biol Phys, 68(3): 852-7. [Abstract] [Full-text]
16. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
    Int J Radiat Oncol Biol Phys, 68(3): 779-85. [Abstract] [Full-text]
17. What dose of external-beam radiation is high enough for prostate cancer?
    Int J Radiat Oncol Biol Phys, 68(3): 682-9. [Abstract] [Full-text]
18. Dosimetric predictors of laryngeal edema.
    Int J Radiat Oncol Biol Phys, 68(3): 741-9. [Abstract] [Full-text]
19. Prognostic factors depicting disease-specific survival in parotid-gland tumors.
    Int J Radiat Oncol Biol Phys, 68(3): 714-8. [Abstract] [Full-text]
20. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Int J Radiat Oncol Biol Phys, 68(3): 707-13. [Abstract] [Full-text]
21. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
    Int J Radiat Oncol Biol Phys, 68(3): 794-800. [Abstract] [Full-text]
22. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy.
    Int J Radiat Oncol Biol Phys, 68(3): 845-51. [Abstract] [Full-text]
23. Salvage re-irradiation for recurrent head and neck cancer.
    Int J Radiat Oncol Biol Phys, 68(3): 731-40. [Abstract] [Full-text]
24. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution.
    Int J Radiat Oncol Biol Phys, 68(3): 858-63. [Abstract] [Full-text]
25. A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors.
    Int J Radiat Oncol Biol Phys, 68(3): 839-44. [Abstract] [Full-text]
26. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 68(3): 801-8. [Abstract] [Full-text]
27. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
    Int J Radiat Oncol Biol Phys, 68(3): 667-72. [Abstract] [Full-text]
28. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Int J Radiat Oncol Biol Phys, 68(3): 786-93. [Abstract] [Full-text]
29. Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results.
    Int J Radiat Oncol Biol Phys, 68(3): 817-22. [Abstract] [Full-text]
30. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.
    Int J Radiat Oncol Biol Phys, 68(3): 690-8. [Abstract] [Full-text]
31. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
    Int J Radiat Oncol Biol Phys, 68(3): 823-9. [Abstract] [Full-text]
32. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 68(3): 809-16. [Abstract] [Full-text]
33. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients.
    Int J Radiat Oncol Biol Phys, 68(3): 673-81. [Abstract] [Full-text]
34. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer.
    Am J Clin Oncol, 30(3): 310-4. [Abstract] [Full-text]
35. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Am J Clin Oncol, 30(3): 271-7. [Abstract] [Full-text]
36. Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique.
    Am J Clin Oncol, 30(3): 215-9. [Abstract] [Full-text]
37. A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotherapy.
    Br J Radiol, 80(952): 279-83. [Abstract] [Full-text]
38. Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study.
    J Clin Oncol, 25(17): 2383-8. [Abstract] [Full-text]
39. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Cancer, 109(12): 2432-8. [Abstract] [Full-text]
40. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Cancer, 109(12): 2515-21. [Abstract] [Full-text]
41. The effects of RF absorbers on exposure levels at 100 MHz.
    Bioelectromagnetics, 28(5): 406-8. [Abstract] [Full-text]
42. Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques.
    Neurosurg Rev, 30(3): 167-75; discussion 175-6. [Abstract] [Full-text]
43. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma.
    Leuk Res, 31(8): 1141-4. [Abstract] [Full-text]
44. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
    Pediatr Blood Cancer, 49(2): 145-8. [Abstract] [Full-text]
45. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Cancer Chemother Pharmacol, 60(3): 399-406. [Abstract] [Full-text]
46. A comparison of conventional and pulsed radiofrequency denervation in the treatment of chronic facet joint pain.
    Clin J Pain, 23(6): 524-9. [Abstract] [Full-text]
47. 20-year retrospective review of medium dose rate intracavitary brachytherapy in VAIN3.
    Gynecol Oncol, 106(1): 105-11. [Abstract] [Full-text]
48. Finger's "slotted" eye plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumours.
    Br J Ophthalmol, 91(7): 891-4. [Abstract] [Full-text]
49. Relationship between malignant subtypes of meningioma and clinical outcome.
    J Clin Neurosci, 14(8): 747-53. [Abstract] [Full-text]
50. Psychometric properties of a prostate cancer radiation late toxicity questionnaire.
    Health Qual Life Outcomes, 5: 29. [Abstract] [Full-text]

© 2004-2012 Radiotherapy Research Today. All Rights Reserved.